Status:
COMPLETED
The Validity and Reliability Study of the Chelsea Critical Care Physical Assesment Tool
Lead Sponsor:
Saglik Bilimleri Universitesi
Collaborating Sponsors:
Medical Park Hospital Istanbul
Conditions:
ICU Patients
ICU Acquired Weakness
Eligibility:
All Genders
18-85 years
Brief Summary
This study is aimed at providing an translation and cross-cultural adaptation of Chelsea Critical Care Physical Assesment Tool (CPAx) and tested its reliability and validity.
Detailed Description
Survival has increased in the ICU due to technological developments , but physical disability after discharge has become an important problem. İntensive Care Unit Acquired Weakness(ICU-AW) is seen in ...
Eligibility Criteria
Inclusion
- Older than 18 years
- Critical adult patients
- Patients who were hospitalized for more than 48 hours in an ICU
Exclusion
- Unstable fracture
- Limb deformities and dysfunction
- Myasthenia gravis
- Neuromuscular dysfunction
- Patients who diagnosed COVİD-19
Key Trial Info
Start Date :
January 11 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 14 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04811638
Start Date
January 11 2021
End Date
January 14 2021
Last Update
August 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mehmet Burak Uyaroğlu
Istanbul, Turkey (Türkiye), 34415